These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 8380374
1. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. Catzeflis C, Pierroz DD, Rohner-Jeanrenaud F, Rivier JE, Sizonenko PC, Aubert ML. Endocrinology; 1993 Jan; 132(1):224-34. PubMed ID: 8380374 [Abstract] [Full Text] [Related]
2. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats. Pierroz DD, Catzeflis C, Aebi AC, Rivier JE, Aubert ML. Endocrinology; 1996 Jan; 137(1):3-12. PubMed ID: 8536627 [Abstract] [Full Text] [Related]
3. Evidence that neuropeptide Y could represent a neuroendocrine inhibitor of sexual maturation in unfavorable metabolic conditions in the rat. Gruaz NM, Pierroz DD, Rohner-Jeanrenaud F, Sizonenko PC, Aubert ML. Endocrinology; 1993 Oct; 133(4):1891-4. PubMed ID: 8404631 [Abstract] [Full Text] [Related]
4. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes. Raposinho PD, Castillo E, d'Alleves V, Broqua P, Pralong FP, Aubert ML. Endocrinology; 2000 Dec; 141(12):4419-27. PubMed ID: 11108250 [Abstract] [Full Text] [Related]
5. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, Kahn SE, Baskin DG, Woods SC, Figlewicz DP. Endocrinology; 1992 Jun; 130(6):3608-16. PubMed ID: 1597158 [Abstract] [Full Text] [Related]
6. The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat. Raposinho PD, White RB, Aubert ML. J Neuroendocrinol; 2003 Feb; 15(2):173-81. PubMed ID: 12535159 [Abstract] [Full Text] [Related]
7. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis. Fekete C, Sarkar S, Rand WM, Harney JW, Emerson CH, Bianco AC, Beck-Sickinger A, Lechan RM. Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577 [Abstract] [Full Text] [Related]
8. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors. Jain MR, Pu S, Kalra PS, Kalra SP. Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146 [Abstract] [Full Text] [Related]
9. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice. Park S, Peng XD, Frohman LA, Kineman RD. Neuroendocrinology; 2005 Nov; 81(6):360-71. PubMed ID: 16244497 [Abstract] [Full Text] [Related]
11. Chronic administration of neuropeptide Y into the lateral ventricle starting at 30 days of life delays sexual maturation in the female rat. Pierroz DD, Gruaz NM, d'Alièves V, Aubert ML. Neuroendocrinology; 1995 Mar; 61(3):293-300. PubMed ID: 7898634 [Abstract] [Full Text] [Related]
12. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype. Raposinho PD, Broqua P, Pierroz DD, Hayward A, Dumont Y, Quirion R, Junien JL, Aubert ML. Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275 [Abstract] [Full Text] [Related]
13. Neuropeptide-Y stimulates growth hormone and gonadotropin-II secretion in the goldfish pituitary: involvement of both presynaptic and pituitary cell actions. Peng C, Chang JP, Yu KL, Wong AO, Van Goor F, Peter RE, Rivier JE. Endocrinology; 1993 Apr; 132(4):1820-9. PubMed ID: 8462479 [Abstract] [Full Text] [Related]
14. Neuropeptide Y potentiates luteinizing hormone (LH)-releasing hormone-induced LH secretion only under conditions leading to preovulatory LH surges. Bauer-Dantoin AC, McDonald JK, Levine JE. Endocrinology; 1992 Dec; 131(6):2946-52. PubMed ID: 1446632 [Abstract] [Full Text] [Related]
15. Neuropeptide-Y suppresses pulsatile secretion of luteinizing hormone in ovariectomized rats: possible site of action. McDonald JK, Lumpkin MD, DePaolo LV. Endocrinology; 1989 Jul; 125(1):186-91. PubMed ID: 2661205 [Abstract] [Full Text] [Related]
17. Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis. Fekete C, Kelly J, Mihály E, Sarkar S, Rand WM, Légrádi G, Emerson CH, Lechan RM. Endocrinology; 2001 Jun; 142(6):2606-13. PubMed ID: 11356711 [Abstract] [Full Text] [Related]
18. Increased galanin and neuropeptide-Y immunoreactivity within the hypothalamus of ovariectomised ewes following a prolonged period of reduced body weight is associated with changes in plasma growth hormone but not gonadotropin levels. Barker-Gibb ML, Clarke IJ. Neuroendocrinology; 1996 Sep; 64(3):194-207. PubMed ID: 8875437 [Abstract] [Full Text] [Related]
19. Control of feeding and sexual behaviors by neuropeptide Y: physiological implications. Kalra SP, Clark JT, Sahu A, Dube MG, Kalra PS. Synapse; 1988 Sep; 2(3):254-7. PubMed ID: 3212671 [Abstract] [Full Text] [Related]
20. Chronic intracerebroventricular administration of anti-neuropeptide Y antibody stimulates starvation-induced feeding via compensatory responses in the hypothalamus. Ishii T, Muranaka R, Tashiro O, Nishimura M. Brain Res; 2007 May 04; 1144():91-100. PubMed ID: 17320051 [Abstract] [Full Text] [Related] Page: [Next] [New Search]